Literature DB >> 35258640

A review: traditional herbs and remedies impacting pathogenesis of Parkinson's disease.

Vishavdeep Sharma1, Onkar Bedi2, Manisha Gupta2, Rahul Deshmukh3,4.   

Abstract

Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic neurons, leading to misbalance and loss of coordination. Current therapies are claimed only for symptomatic relief, on long-term use, which causes alteration in basal ganglia, and give rise to various adverse effects like dyskinesia and extra pyramidal side effects, which is reversed and proved to be attenuated with the help of various herbal approaches. Therefore, in order to attenuate the dopaminergic complications, focus of current research has been shifted from dopaminergic to non-dopaminergic strategies. Herbs and herbal remedies seems to be a better option to overcome the complications associated with current dopaminergic therapies. In recent years, various herbs and herbal remedies based on Ayurveda, traditional Chinese and Korean remedies, have become the target of various researches. These herbs and their bioactive compound are being extensively used to treat PD in India, China, Japan, and Korea. The major focus of this current review is to analyze preclinical studies with reference to various herbs, bioactive compounds, and traditional remedies for the management of Parkinson disorder, which will give an insight towards clinical trials.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chemical constituents; Chinese herb; Dopamine Transporter; Excitotoxicity; Herbals; Neurobiology; Parkinson disorder; Traditional medicine

Mesh:

Substances:

Year:  2022        PMID: 35258640     DOI: 10.1007/s00210-022-02223-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  128 in total

1.  The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease.

Authors:  Nayoung Bae; Taekwon Ahn; Sungkwon Chung; Myung Sook Oh; Hyeonseok Ko; Hyungun Oh; Gunhyuk Park; Hyun Ok Yang
Journal:  J Ethnopharmacol       Date:  2010-12-21       Impact factor: 4.360

2.  Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats.

Authors:  Muzamil Ahmad; Sofiyan Saleem; Abdullah Shafique Ahmad; Mubeen Ahmad Ansari; Seema Yousuf; Md Nasrul Hoda; Fakhrul Islam
Journal:  Hum Exp Toxicol       Date:  2005-03       Impact factor: 2.903

Review 3.  Cellular models to investigate biochemical pathways in Parkinson's disease.

Authors:  Tiziana Alberio; Leonardo Lopiano; Mauro Fasano
Journal:  FEBS J       Date:  2012-02-28       Impact factor: 5.542

4.  Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells.

Authors:  Hua An; In Su Kim; Sushruta Koppula; Byung Wook Kim; Pyo Jam Park; Beong Ou Lim; Wahn Soo Choi; Kwang Ho Lee; Dong Kug Choi
Journal:  J Ethnopharmacol       Date:  2010-05-12       Impact factor: 4.360

5.  A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease.

Authors:  C D Binde; I F Tvete; J Gåsemyr; B Natvig; M Klemp
Journal:  Br J Clin Pharmacol       Date:  2018-06-25       Impact factor: 4.335

Review 6.  The potential role of herbal products in the treatment of Parkinson's disease.

Authors:  M S Amro; S L Teoh; A G Norzana; D Srijit
Journal:  Clin Ter       Date:  2018 Jan-Feb

7.  The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats.

Authors:  R Bridi; F P Crossetti; V M Steffen; A T Henriques
Journal:  Phytother Res       Date:  2001-08       Impact factor: 5.878

8.  Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias.

Authors:  Imtiaz Ahmed; Subrata K Bose; Nicola Pavese; Anil Ramlackhansingh; Federico Turkheimer; Gary Hotton; Alexander Hammers; David J Brooks
Journal:  Brain       Date:  2011-03-02       Impact factor: 13.501

9.  Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Exp Neurol       Date:  2008-04-15       Impact factor: 5.330

10.  Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.

Authors:  Peter D Alfinito; Sheng-Ping Wang; Lawrence Manzino; Sonia Rijhsinghani; Gail D Zeevalk; Patricia K Sonsalla
Journal:  J Neurosci       Date:  2003-11-26       Impact factor: 6.167

View more
  1 in total

1.  Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson's disease.

Authors:  Yu-Chen Yan; Zhi-Heng Xu; Jian Wang; Wen-Bo Yu
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.